COPD and type 2 diabetes: do antidiabetic drugs reduce acute exacerbations?

被引：0
|
作者：
Simon, Annika
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2023年 / 148卷 / 03期
关键词：
D O I：
10.1055/a-1980-9069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Viele Menschen mit Diabetes Typ 2 leiden an weiteren Komorbiditaten, wie beispielsweise einer chronisch obstruktiven Lungenerkrankung (COPD). Da die Diabeteserkrankung regelhaft medikamentos behandelt wird, ergibt sich die Frage nach positiven Effekten neuer Antidiabetika auf Haufigkeit und Schwere von Exazerbationen der Lungenerkrankung. Pradhan et al. haben hier angesetzt und stellen nun ihre populationsbasierte Kohortenstudie zum Thema vor.
引用
收藏
页码：71 / 71
页数：1
相关论文
共 50 条
  • [31] Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
    Ruiz-Tamayo, Irene
    Franch-Nadal, Josep
    Mata-Cases, Manel
    Mauricio, Didac
    Cos, Xavier
    Rodriguez-Poncelas, Antonio
    Barrot, Joan
    Coll-de-Tuero, Gabriel
    Mundet-Tuduri, Xavier
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [32] Potentially inappropriate prescribing of antidiabetic drugs and impact on outcomes in patients with type 2 diabetes
    Saleh, Shadi S.
    Carter, Judith
    Plauschinat, Craig A.
    Szebenyi, Steven E.
    DIABETES, 2007, 56 : A156 - A156
  • [33] Safety of metformin use in COPD patients with type 2 diabetes requiring hospital admission for exacerbations
    Turner, Luke
    Cull, Richard
    Archer, John R. H.
    Srivastava, Shelley A.
    Baker, Emma H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 290 - 291
  • [34] Frequency of Administration of Antidiabetic Drugs According to the GFR Level in Type 2 Diabetes Patients
    Papazafiropoulou, Athanasia K.
    Koutsovasilis, Anastasios G.
    Kokolaki, Anthi
    Kardara, Marina
    Sotiropoulos, Alexis
    Da, Maria Babour
    Vergidou, Paraskevi
    Gougourelas, Dimitrios M. D.
    Bousboulas, Stavros
    Pappas, Stavros
    DIABETES, 2014, 63 : A403 - A403
  • [35] Depression but not non-persistence to antidiabetic drugs is associated with mortality in type 2 diabetes
    Lunghi, Carlotta
    Zongo, Arsene
    Tardif, Isabelle
    Demers, Eric
    Diendere, Joel D. R.
    Guenette, Line
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 299 - 300
  • [36] Relationship between adherence to oral antidiabetic drugs and control of type 2 diabetes mellitus
    Esquivel-Prados, E.
    Pareja-Martinez, E.
    Garcia-Corpas, J. P.
    JOURNAL OF HEALTHCARE QUALITY RESEARCH, 2024, 39 (06) : 346 - 355
  • [37] Do air pollution and outdoor temperature influence the frequency of acute COPD exacerbations?
    Krachunov, Iliya
    Yanev, Nikolay
    Kyuchukov, Nikolay
    Ivanova, Zlatina
    Hristova, Petkana
    Glogovsks, Pavlina
    Pavlov, Plamen
    Popova, Tsanya
    Ivanov, Yavor
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [38] COPD and Type 2 Diabetes
    Mamillapalli, Chaitanya
    Tentu, Ramesh
    Jain, Nitesh Kumar
    Bhandari, Ramanath
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (02) : 112 - 119
  • [39] Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
    Liu, Geng
    Zhong, Xueyu
    Zheng, Juan
    Zhang, Jiaoyue
    Kong, Wen
    Hu, Xiang
    Min, Jie
    Xia, Wenfang
    Zeng, Tianshu
    Chen, Lulu
    DIABETES THERAPY, 2023, 14 (05) : 789 - 822
  • [40] Oral antidiabetic drugs adherence and glycemic control among patients with type 2 diabetes mellitus
    Balkhi, Bander
    Alhawassi, Tariq
    Alshammari, Thamir
    AlQahtani, Nasser
    Almetwazi, Mansour
    Mahmoud, Mansour
    Ata, Sondus
    Basyoni, Mada
    Alwhaibi, Monira
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 59 - 60
12345